Marc G Besselink
Overview
Explore the profile of Marc G Besselink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
650
Citations
12806
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zwart M, van den Broek B, Zwetsloot S, Busch O, Tran T, Luyer M, et al.
Ann Surg
. 2025 Feb;
PMID: 39957661
Objective: To determine if video grading using Objective Structured Assessment of Technical Skills (OSATS) could estimate the risk of postoperative bile leak (BL) after robotic pancreatoduodenectomy (RPD) and to identify...
12.
Habib J, Javed A, Molenaar I, Wolfgang C, Besselink M
J Natl Cancer Inst
. 2025 Feb;
PMID: 39945800
No abstract available.
13.
Joseph N, Liu G, Varghese C, Lim W, Xu W, Wells C, et al.
Pancreas
. 2025 Feb;
54(2):e82-e88.
PMID: 39928886
Background: This systematic review assessed the volume and methodological quality of randomized controlled trials (RCTs) in relation to management of acute pancreatitis (AP). Materials And Methods: The PubMed, MEDLINE, and...
14.
Menso J, Francken M, de Graaf N, Bonomi A, Guastella R, Balaban D, et al.
Ann Surg
. 2025 Feb;
PMID: 39928538
Objective: To perform a cost-analysis during the implementation of robot-assisted pancreatoduodenectomy (RPD) in a high-volume center. Background: Many high-volume centers are implementing RPD as alternative to open pancreatoduodenectomy (OPD) but...
15.
Javed A, Habib J, Andel P, Campbell B, Rompen I, Mahmud O, et al.
Ann Surg
. 2025 Feb;
PMID: 39928537
Objective: The aim of the study was to investigate prognostic factors in context of neoadjuvant therapy (NAT) and develop tools that can allow for accurate and personalized patient prognostication. Summary...
16.
Reese T, Gilg S, Besselink M, Soreide K
HPB (Oxford)
. 2025 Feb;
PMID: 39924370
Background: Fellowships in HPB surgery are lacking across Europe. The aim of this survey was to investigate preferences towards an HPB-fellowship structure among trainees and trainers. Methods: A cross-sectional pan-European...
17.
Ghadimi M, Pelzer U, Besselink M, Siveke J, Telgmann R, Braren R, et al.
BMC Cancer
. 2025 Feb;
25(1):208.
PMID: 39915735
Background: Based on current guidelines, surgical treatment of hepatic oligometastases in patients with pancreatic ductal adenocarcinoma (PDAC) is not primarily recommended. Systematic chemotherapy is the therapy of choice for these...
18.
Dekker E, Janssen Q, van Dam J, Strijk G, Verkolf E, Kandala S, et al.
Ann Surg Oncol
. 2025 Feb;
PMID: 39907876
Background: This study aimed to investigate the feasibility and yield of blood sample collection in an investigator-initiated nationwide randomized controlled trial (RCT). Methods: In the PREOPANC-2 trial, 375 patients with...
19.
Gehrels A, Vissers P, Sprangers M, Fijnheer N, Pijnappel E, van der Geest L, et al.
EClinicalMedicine
. 2025 Feb;
80:103068.
PMID: 39902316
Background: Pancreatic adenocarcinoma (PAC) has a poor prognosis and substantially impairs health-related quality of life (HRQoL). Large studies on longitudinal HRQoL in patients with PAC, taking patient treatment into account,...
20.
Wismans L, Hendriks T, Suurmeijer J, Nuyttens J, Bruynzeel A, Intven M, et al.
Br J Surg
. 2025 Feb;
112(2).
PMID: 39891429
Background: Postoperative pancreatic fistula is the main driver of morbidity and mortality after pancreatoduodenectomy. In high-risk patients, the rate of postoperative pancreatic fistula approaches 50%, whereas it is below 5%...